Cost of Hepatitis C drug means major state Medicaid spend. Capital. New York state’s Medicaid program spent $193.2 million during the first six months of 2014 on Sovaldi, the controversial Hepatitis C drug that carries an $84,000-per-patient price tag. In the first six months of 2014, 6,911 prescriptions were written for Sovaldi for a 12-week course of treatment.
The Hepatitis A, B and C in NYC: 2021 Annual Report provides the latest surveillance and programmatic data on viral hepatitis in NYC.
The USPSTF gives a “B” rating for testing hepatitis C among injection drug users and others at high risk, a major improvement over previous guidelines However, the Task Force failed to match the Centers for Disease Control and Prevention’s lifesaving recommendation of testi...
The American Medical Association launched a website for consumers to tell their stories of how rising prices are affecting their health and their pocketbooks.
This report presents an overview of the NYC Health Department’s 2018 surveillance and research data on hepatitis B and C in NYC, as well as the Health Department’s programmatic activities to address these epidemics.
Position will be responsible for leading projects to advance local health department program efforts to adapt their HIV, STI, and hepatitis programs to changes in the public health and healthcare systems resulting from the implementation of the ACA.
The NYS Drug Utilization Review Board voted to eliminate most restrictions on prescribing hepatitis C medications for all Medicaid fee-for-service patients.
Organizations wishing to receive City Council funding in FY 2019 must complete Discretionary Funding application by February 20, 2018.
Are you on Medicaid and receive medication coverage information from one of the plans below?
